Renovaro (RENB) Stock Chart & Stock Price History → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free RENB Stock Alerts $1.49 +0.02 (+1.36%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Renovaro Stock Price Performance5 Day Performance+1.36%1 Month Performance0.00%3 Month Performance-35.50%6 Month Performance-54.98%Year-To-Date Performance-53.00% Receive RENB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. RENB Stock Chart for Sunday, June, 2, 2024 RENB Chart by TradingView Renovaro Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.47$1.49+1.36%$1.58$1.45242,715 shs$219.79 million05/30/2024$1.47$1.47$1.57$1.36380,273 shs$216.84 million05/29/2024$1.47$1.47$1.50$1.32233,625 shs$216.84 million05/28/2024$1.42$1.47+3.52%$1.75$1.451.17 million shs$216.83 million05/27/2024$1.42$1.42$1.49$1.201.14 million shs$209.46 million05/24/2024$1.32$1.42+7.58%$1.49$1.201.14 million shs$209.46 million Get the Latest News and Ratings for RENB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.94$1.32+40.43%$1.61$1.004.92 million shs$194.71 million05/22/2024$0.96$0.94-2.08%$1.00$0.9369,746 shs$138.66 million05/21/2024$0.97$0.96-1.03%$1.08$0.87153,667 shs$141.61 million05/20/2024$0.97$0.97$1.16$0.94320,433 shs$143.09 million05/17/2024$0.92$0.97+5.75%$1.00$0.90153,451 shs$139.36 million05/16/2024$0.95$0.92-3.17%$1.17$0.82359,562 shs$131.79 million05/15/2024$1.04$0.95-8.91%$1.13$0.90236,904 shs$136.10 million05/14/2024$1.16$1.04-10.34%$1.17$1.01258,467 shs$149.42 million05/13/2024$1.13$1.16+2.65%$1.28$1.10235,511 shs$166.66 million05/10/2024$1.20$1.13-5.83%$1.26$1.13189,529 shs$162.35 million05/09/2024$1.46$1.20-17.81%$1.48$1.18206,632 shs$172.40 million05/08/2024$1.49$1.46-2.01%$1.55$1.32269,281 shs$209.76 million05/07/2024$1.48$1.49+0.68%$1.52$1.44241,582 shs$214.07 million05/06/2024$1.50$1.48-1.33%$1.55$1.48177,717 shs$212.63 million05/03/2024$1.49$1.50+0.67%$1.58$1.45307,480 shs$214.07 million05/02/2024$1.47$1.49+1.36%$1.58$1.42217,116 shs$214.07 million05/01/2024$1.58$1.47-6.96%$1.61$1.45451,182 shs$211.20 million04/30/2024$1.56$1.58+1.28%$1.84$1.501.00 million shs$227.00 million04/29/2024$1.53$1.56+1.96%$1.62$1.24439,479 shs$224.13 million04/26/2024$1.70$1.53-10.00%$2.10$1.501.04 million shs$219.82 million04/25/2024$1.97$1.70-13.71%$1.99$1.56427,977 shs$244.24 million04/24/2024$2.02$1.97-2.48%$2.09$1.89206,935 shs$283.03 million04/23/2024$2.15$2.02-6.05%$2.18$1.93292,609 shs$290.21 million04/22/2024$2.17$2.15-0.92%$2.20$2.11110,931 shs$308.89 million04/19/2024$2.30$2.17-5.65%$2.28$1.98207,910 shs$144.74 million04/18/2024$2.22$2.30+3.60%$2.38$2.13127,476 shs$153.41 million04/17/2024$2.42$2.22-8.26%$2.45$2.19157,145 shs$148.07 million04/16/2024$2.45$2.42-1.22%$2.70$2.34200,427 shs$161.41 million04/15/2024$2.36$2.45+3.81%$2.62$2.28424,118 shs$163.42 million04/12/2024$2.45$2.36-3.67%$2.52$2.26238,740 shs$157.41 million04/11/2024$2.48$2.45-1.21%$2.61$2.38311,926 shs$163.42 million04/10/2024$2.79$2.48-11.11%$2.84$2.43212,540 shs$165.42 million04/09/2024$2.85$2.79-2.11%$2.97$2.71131,571 shs$186.09 million04/08/2024$2.76$2.85+3.26%$2.93$2.65165,117 shs$190.10 millionTrump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.04/05/2024$2.79$2.76-1.08%$2.94$2.59248,697 shs$184.09 million04/04/2024$2.77$2.79+0.72%$2.90$2.7296,022 shs$186.09 million04/03/2024$2.82$2.77-1.77%$2.88$2.7455,280 shs$184.76 million04/02/2024$3.00$2.82-6.00%$3.00$2.75110,403 shs$188.09 million04/01/2024$2.65$3.00+13.21%$3.05$2.61151,060 shs$200.10 million03/29/2024$2.65$2.65$2.79$2.62130,729 shs$176.76 million03/28/2024$2.79$2.65-5.02%$2.79$2.62131,077 shs$176.76 million03/27/2024$2.92$2.79-4.45%$3.00$2.76243,132 shs$186.09 million03/26/2024$2.91$2.92+0.34%$3.04$2.84107,819 shs$194.76 million03/25/2024$3.23$2.91-9.91%$3.13$2.80311,024 shs$194.09 million03/22/2024$2.94$3.23+9.86%$3.24$2.85117,150 shs$215.44 million03/21/2024$2.91$2.94+1.03%$2.94$2.77229,150 shs$196.10 million03/20/2024$3.20$2.91-9.06%$3.17$2.79206,628 shs$194.09 million03/19/2024$3.00$3.20+6.67%$3.20$2.801.03 million shs$213.44 million03/18/2024$3.17$3.00-5.36%$3.13$2.871.10 million shs$200.10 million03/15/2024$3.13$3.17+1.28%$3.25$2.971.49 million shs$211.43 million03/14/2024$3.01$3.13+3.99%$3.17$2.83882,750 shs$208.77 million03/13/2024$3.11$3.01-3.22%$3.15$2.801.04 million shs$200.77 million03/12/2024$2.98$3.11+4.36%$3.21$2.93264,647 shs$207.44 million03/11/2024$3.13$2.98-4.79%$3.28$2.96359,289 shs$198.76 million03/08/2024$2.99$3.13+4.68%$3.38$2.87334,077 shs$208.77 million03/07/2024$2.66$2.99+12.41%$3.17$2.62415,059 shs$199.43 million03/06/2024$2.42$2.66+9.92%$2.69$2.42226,196 shs$177.42 million03/05/2024$2.61$2.42-7.28%$2.82$2.41324,412 shs$161.41 million03/04/2024$2.31$2.61+12.99%$2.85$2.20596,005 shs$174.09 million03/01/2024$2.58$2.31-10.47%$2.50$2.23138,435 shs$154.08 million Related Companies: Conduit Pharmaceuticals Stock Price Chart Werewolf Therapeutics Stock Price Chart Ovid Therapeutics Stock Price Chart G1 Therapeutics Stock Price Chart Generation Bio Stock Price Chart Eliem Therapeutics Stock Price Chart Rani Therapeutics Stock Price Chart Zevra Therapeutics Stock Price Chart Pyxis Oncology Stock Price Chart Prelude Therapeutics Stock Price Chart Receive RENB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Renovaro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RENB) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.